跳至主要内容
临床试验/NL-OMON53606
NL-OMON53606尚未招募不适用

At-home Monitoring of patients during Chemoradiation for Oesophageal canceR: the AMCOR trial - the AMCOR trial

niversitair Medisch Centrum Groningen0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >= 18 at the time of signing informed consent.
  • 2. Histologically proven adenocarcinoma, squamous cell carcinoma or mixed type
  • of the oesophagus or gastro-oesophageal junction.
  • 3. Indication for definitive or neoadjuvant CRT, with chemotherapy that
  • consists of weekly carboplatin/paclitaxel.
  • 4. Written, informed consent.
  • 5. Ability to comply with all protocol required actions (at home measurements
  • are done individually by the participant him- or herself).

排除标准

  • 1. Altered mental status, or any psychiatric condition that would prohibit the
  • understanding or rendering of informed consent or the carrying out of the
  • measurements at home.

研究者

相似试验